VOLHA DANIEL: Open Payments
NPI 1720730096 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,718 in 79 payments from 20 companies in 2025. Trend: 2023 $580 · 2024 $920 · 2025 $1,718
Food & beverage: $1,718
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $341 |
| Amgen Inc. | 15 | $267 |
| AstraZeneca Pharmaceuticals LP | 3 | $226 |
| GlaxoSmithKline, LLC. | 14 | $155 |
| PFIZER INC. | 7 | $148 |
| ABBVIE INC. | 5 | $118 |
| SANOFI-AVENTIS U.S. LLC | 2 | $76 |
| Esperion Therapeutics, Inc. | 3 | $58 |
| Sumitomo Pharma America, Inc. | 3 | $47 |
| Astellas Pharma US Inc | 2 | $47 |
Products named: EVENITY, Ozempic, BREZTRI, TRELEGY ELLIPTA, Rybelsus, AIRSUPRA, TZIELD, ELIQUIS.
Industry payments across FL — which companies pay providers there.
